FindTrial
Sign In

Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GERD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01324791
Enrollment
Unknown
Registered
2011-03-29
Start date
Unknown
Completion date
Unknown
Last updated
2011-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Brief summary

Endoscopic full thickness gastroplication (Plicator-Procedure) has the potential to be a safe and effective alternative to laparoscopic antireflux surgery (LARS)to improve symptoms of GERD. This prospective randomized study compares objective and subjective outcome parameters of Plicator with that of LARS.

Interventions

PROCEDUREanti-reflux surgery

Sponsors

General Public Hospital Zell am See
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* long history of GERD symptoms * persistent or recurrent symptoms despite optimal medical treatment * persistent or recurrent complications of GERD * reduced quality of life owing to increasing esophageal exposure to gastric juice * pathological values in the preoperative evaluated functional parameters.

Exclusion criteria

* any distinct hiatal hernia detectable by gastroscopy or barium radiography * dysphagia * esophageal strictures * poor physical status (American Society of Anesthesiologists (ASA) scores III and IV) and pregnancy.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026